Arq Bras Cardiol
January 2017
Background: The prevalence of atherosclerosis is higher in HIV-positive people, who also experience it earlier than the general population.
Objectives: To assess and compare the prevalence of atherosclerosis evaluated by the intima-media thickness of carotid and femoral arteries, and by the ankle-brachial pressure index (ABPI) in HIV patients treated or not treated with protease inhibitors (PIs) and controls.
Methods: Eighty HIV+ subjects (40 using PIs and 40 not using PIs) and 65 controls were included in the study.